Physician profile
Peter R Schultz
NPI 1013942572
$966.40
in general payments reported to CMS, 2019-2025
19 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $35.08 · 2022: $24.91 · 2023: $142 · 2024: $386 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $906.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $906.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $170.98 | 2025 | Strata |
| Ucb, INC. | $91.53 | 2024 | Fintepla |
| Abbvie INC. | $87.70 | 2024-2025 | |
| Novartis Pharmaceuticals Corporation | $73.44 | 2024-2025 | |
| Lilly USA, LLC | $64.66 | 2024-2025 | Amyvid, Kisunla |
| Alexion Pharmaceuticals, INC. | $53.52 | 2024 | Ultomiris |
| Eisai INC. | $46.84 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $43.72 | 2023-2024 | Andexxa |
| Sk Life Science, INC. | $43.55 | 2023-2024 | |
| Stryker Corporation | $40.05 | 2023 | Omnicurve, Spinejack |
| Emd Serono, INC. | $39.95 | 2024-2025 | |
| Integra Lifesciences Corporation | $37.94 | 2023-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kci USA, INC. | $35.08 | 2021 | |
| Boston Scientific Corporation | $32.19 | 2025 | General - Pain Management |
| Neurelis, INC. | $24.91 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $23.16 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Biogen, INC. | $19.45 | 2025 | Vumerity, Tysabri |
| Bioventus LLC | $18.98 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Augmedics INC. | $18.75 | 2023 | Xvision |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.